These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

562 related items for PubMed ID: 7850718

  • 1. An open-label, multicenter study of polyethylene glycol-L-asparaginase for the treatment of acute lymphoblastic leukemia.
    Ettinger LJ, Kurtzberg J, Voûte PA, Jürgens H, Halpern SL.
    Cancer; 1995 Mar 01; 75(5):1176-81. PubMed ID: 7850718
    [Abstract] [Full Text] [Related]

  • 2. Polyethylene Glycol-conjugated L-asparaginase versus native L-asparaginase in combination with standard agents for children with acute lymphoblastic leukemia in second bone marrow relapse: a Children's Oncology Group Study (POG 8866).
    Kurtzberg J, Asselin B, Bernstein M, Buchanan GR, Pollock BH, Camitta BM.
    J Pediatr Hematol Oncol; 2011 Dec 01; 33(8):610-6. PubMed ID: 22042277
    [Abstract] [Full Text] [Related]

  • 3. FDA drug approval summary: pegaspargase (oncaspar) for the first-line treatment of children with acute lymphoblastic leukemia (ALL).
    Dinndorf PA, Gootenberg J, Cohen MH, Keegan P, Pazdur R.
    Oncologist; 2007 Aug 01; 12(8):991-8. PubMed ID: 17766659
    [Abstract] [Full Text] [Related]

  • 4. Intravenous pegylated asparaginase versus intramuscular native Escherichia coli L-asparaginase in newly diagnosed childhood acute lymphoblastic leukaemia (DFCI 05-001): a randomised, open-label phase 3 trial.
    Place AE, Stevenson KE, Vrooman LM, Harris MH, Hunt SK, O'Brien JE, Supko JG, Asselin BL, Athale UH, Clavell LA, Cole PD, Kelly KM, Laverdiere C, Leclerc JM, Michon B, Schorin MA, Welch JJ, Lipshultz SE, Kutok JL, Blonquist TM, Neuberg DS, Sallan SE, Silverman LB.
    Lancet Oncol; 2015 Dec 01; 16(16):1677-90. PubMed ID: 26549586
    [Abstract] [Full Text] [Related]

  • 5. [Comparison of polyethylene glycol conjugated asparaginase and L-asparaginase for treatment of childhood acute lymphoblastic leukemia].
    Cooperation Group of Phase II Clinical Trial of PEG-Aspzhuxiaof@yahoo.com.cn.
    Zhonghua Xue Ye Xue Za Zhi; 2008 Jan 01; 29(1):29-33. PubMed ID: 18512312
    [Abstract] [Full Text] [Related]

  • 6. Weekly polyethylene glycol conjugated L-asparaginase compared with biweekly dosing produces superior induction remission rates in childhood relapsed acute lymphoblastic leukemia: a Pediatric Oncology Group Study.
    Abshire TC, Pollock BH, Billett AL, Bradley P, Buchanan GR.
    Blood; 2000 Sep 01; 96(5):1709-15. PubMed ID: 10961868
    [Abstract] [Full Text] [Related]

  • 7. Anaphylactic reaction to polyethylene-glycol conjugated-asparaginase: premedication and desensitization may not be sufficient.
    Sahiner UM, Yavuz ST, Gökce M, Buyuktiryaki B, Altan I, Aytac S, Tuncer M, Tuncer A, Sackesen C.
    Pediatr Int; 2013 Aug 01; 55(4):531-3. PubMed ID: 23910807
    [Abstract] [Full Text] [Related]

  • 8. [Clinical experiences with polyethylene glycol-bound E. coli L-asparaginase in patients with multiple recurrences of acute lymphoblastic leukemia].
    Jürgens H, Schwamborn D, Körholz D, Wahn V, Göbel U.
    Klin Padiatr; 1988 Aug 01; 200(3):184-9. PubMed ID: 3210651
    [Abstract] [Full Text] [Related]

  • 9. [Efficacy observation of polyethylene glycol conjugated asparaginase for induction treatment of children with newly diagnosed acute lymphoblastic leukemia].
    Liu F, Wan Y, Chang L, Guo Y, Yang W, Wang S, Chen X, Liu T, Ruan M, Zhang L, Liu X, Zou Y, Chen Y, Zhu X.
    Zhonghua Er Ke Za Zhi; 2014 Mar 01; 52(3):215-7. PubMed ID: 24824393
    [Abstract] [Full Text] [Related]

  • 10. Asparaginase-associated pancreatitis in children with acute lymphoblastic leukaemia in the NOPHO ALL2008 protocol.
    Raja RA, Schmiegelow K, Albertsen BK, Prunsild K, Zeller B, Vaitkeviciene G, Abrahamsson J, Heyman M, Taskinen M, Harila-Saari A, Kanerva J, Frandsen TL, Nordic Society of Paediatric Haematology and Oncology (NOPHO) group.
    Br J Haematol; 2014 Apr 01; 165(1):126-33. PubMed ID: 24428625
    [Abstract] [Full Text] [Related]

  • 11. Evaluation of L-asparaginase: polyethylene glycol conjugate versus native L-asparaginase combined with chemotherapy. A randomized double-blind study in canine lymphoma.
    MacEwen EG, Rosenthal RC, Fox LE, Loar AS, Kurzman ID.
    J Vet Intern Med; 1992 Apr 01; 6(4):230-4. PubMed ID: 1522554
    [Abstract] [Full Text] [Related]

  • 12. Asparaginase pharmacokinetics after intensive polyethylene glycol-conjugated L-asparaginase therapy for children with relapsed acute lymphoblastic leukemia.
    Hawkins DS, Park JR, Thomson BG, Felgenhauer JL, Holcenberg JS, Panosyan EH, Avramis VI.
    Clin Cancer Res; 2004 Aug 15; 10(16):5335-41. PubMed ID: 15328169
    [Abstract] [Full Text] [Related]

  • 13. Successful use of octreotide as a chemoprotectant for prevention of PEG-asparaginase-induced pancreatitis.
    Buie LW, Moore J, van Deventer H.
    Pharmacotherapy; 2014 Aug 15; 34(8):e149-51. PubMed ID: 25112526
    [Abstract] [Full Text] [Related]

  • 14. PEG-asparaginase allergy in children with acute lymphoblastic leukemia in the NOPHO ALL2008 protocol.
    Henriksen LT, Harila-Saari A, Ruud E, Abrahamsson J, Pruunsild K, Vaitkeviciene G, Jónsson ÓG, Schmiegelow K, Heyman M, Schrøder H, Albertsen BK, Nordic Society of Paediatric Haematology and Oncology (NOPHO) group.
    Pediatr Blood Cancer; 2015 Mar 15; 62(3):427-33. PubMed ID: 25418987
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Pharmacokinetic and pharmacodynamic properties of calaspargase pegol Escherichia coli L-asparaginase in the treatment of patients with acute lymphoblastic leukemia: results from Children's Oncology Group Study AALL07P4.
    Angiolillo AL, Schore RJ, Devidas M, Borowitz MJ, Carroll AJ, Gastier-Foster JM, Heerema NA, Keilani T, Lane AR, Loh ML, Reaman GH, Adamson PC, Wood B, Wood C, Zheng HW, Raetz EA, Winick NJ, Carroll WL, Hunger SP.
    J Clin Oncol; 2014 Dec 01; 32(34):3874-82. PubMed ID: 25348002
    [Abstract] [Full Text] [Related]

  • 19. Combination therapy with methotrexate, vincristine, polyethylene-glycol conjugated-asparaginase, and prednisone in the treatment of patients with refractory or recurrent acute lymphoblastic leukemia.
    Aguayo A, Cortes J, Thomas D, Pierce S, Keating M, Kantarjian H.
    Cancer; 1999 Oct 01; 86(7):1203-9. PubMed ID: 10506705
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 29.